Blood markers and skin inflammation in atopic dermatitis
Treatments studied
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study examines a specific blood marker (cfDNA-STING) that may help explain why atopic dermatitis develops. Researchers will compare this marker in people with and without atopic dermatitis to understand the condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years of age or older
- Have a confirmed diagnosis of atopic dermatitis (eczema)
- Not have taken systemic immunosuppressants or systemic corticosteroids in the past 4 weeks
- Not have taken biological agents (biologic medications) in the past 4 weeks
- Not have used topical treatments like creams or ointments on skin in the past 2 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at how atopic dermatitis (eczema), psoriasis, or other autoimmune skin diseases change over time and how the body responds to anti-inflammatory signals. Your information and—if eligible—samples help researchers find patterns that could guide better treatments.
This study looks at skin samples to better understand inflammatory skin diseases. By studying these samples, researchers hope to find new ways to diagnose and treat these conditions.
This study looks at molecular (body-level) signatures in people with chronic inflammatory skin conditions. You may help researchers understand what drives inflammation, while receiving standard (already approved) systemic treatment through routine care.
This study collects blood, urine, and possibly small tissue samples to learn more about cutaneous T-cell lymphoma (CTCL) and either eczema or atopic dermatitis. It may help researchers better understand these skin conditions and improve future treatments.
This study uses special imaging to look at the structure of skin, comparing people with eczema (who have used steroid creams) to healthy volunteers. Researchers want to understand how the skin changes with eczema and its treatment.
Hear when a new Atopic Dermatitis (Eczema) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.